{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-24-001014","form_type":"8-K","ticker":"ALHC","cik":"0001832466","company_name":"Alignment Healthcare, Inc.","filed_at":"2024-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.835490+00:00","generated_at":"2026-06-05T12:47:37.614214+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Alignment Healthcare reports Q4 2023 revenue $465M, up 28.6% YoY; guides FY2024 EBITDA breakeven at midpoint","bullets":["Total revenue $1.82B for FY2023, up 27.2% YoY; health plan members 119,200 at year end, up 21.1% YoY.","Q4 adjusted gross profit $49.2M, medical benefits ratio 89.4%; adjusted EBITDA -$19.7M, net loss -$47.2M.","FY2024 guidance: revenue $2.38-2.41B, health plan members 162k-164k (up ~37% YoY), adjusted EBITDA range -$15M to $15M.","Cash $202.9M, debt $165.0M as of Dec 31, 2023.","Full-year 2023 adjusted gross profit $208.8M, adjusted EBITDA -$35.3M, net loss -$148.2M."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-24-001014","json":"https://secwatch.observer/filing/0001171843-24-001014.json","markdown":"https://secwatch.observer/filing/0001171843-24-001014.md","text":"https://secwatch.observer/filing/0001171843-24-001014.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832466/000117184324001014/0001171843-24-001014-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832466/000117184324001014/f8k_022724.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T12:47:37.614214+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0c1e5ceb803e25f2cba6e12e42428dedd95a91cc","claim":"Alignment Healthcare, Inc. reported fourth quarter ended December 31, 2023 results: revenue $465.4 million, net income $(47.2) million. Guidance initiated.","evidence_excerpt":"Health plan membership at the end of the quarter was approximately 119,200, up 21.1% year over year Total revenue was $465.4 million, up 28.6% year over year Health plan premium revenue of $459.0 million represented 27.5% growth year over year Adjusted gross profit was $49.2 million and loss from operations was ($41.9) million Adjusted gross profit excludes depreciation and amortization of $5.9 million and selling, general, and administrative expenses of $83.7 million (which includes $14.1 million of equity-based compensation). Adjusted gross profit also excludes an additional $1.5 million of equity-based compensation recorded within medical expenses Medical benefits ratio based on adjusted gross profit was 89.4% Adjusted EBITDA was ($19.7) million and net loss was ($47.2) million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832466/000117184324001014/0001171843-24-001014-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter ended December 31, 2023"},{"label":"Revenue","value":"$465.4 million"},{"label":"Net income","value":"$(47.2) million"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"4421af7fc740c3e59c535576d380c5d21bb86960","claim":"Alignment Healthcare, Inc. reported full year ended December 31, 2023 results: revenue $1,823.6 million, net income $(148.2) million. Guidance initiated.","evidence_excerpt":"Total revenue was $1,823.6 million, up 27.2% year over year Health plan premium revenue of $1,800.9 million represented 25.8% growth year over year Adjusted gross profit was $208.8 million and loss from operations was ($127.8) million Adjusted gross profit excludes depreciation and amortization of $21.7 million and selling, general, and administrative expenses of $307.4 million (which includes $59.3 million of equity-based compensation). Adjusted gross profit also excludes an additional $7.5 million of equity-based compensation recorded within medical expenses Medical benefits ratio based on adjusted gross profit was 88.5% Adjusted EBITDA was ($35.3) million and net loss was ($148.2) million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832466/000117184324001014/0001171843-24-001014-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year ended December 31, 2023"},{"label":"Revenue","value":"$1,823.6 million"},{"label":"Net income","value":"$(148.2) million"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}